0
Skip to Content
SMIN Therapeutics
Contact
SMIN Therapeutics
Contact
Contact

SMIN develops oral therapies for autoimmune diseases, initially focused on IgG-mediated indications and FcRn as a central lever. Our PPI discovery platform captures physiologically relevant interactions and accelerates the design of clinically translatable candidates — with the goal of making effective therapies broadly accessible worldwide. The same approach is applicable to additional immune pathways and targets.

SMIN Therapeutics

Contact

contact@smintx.com

Imprint

SMIN Therapeutics GmbH
Elly-See-Str. 1
22547 Hamburg
Germany